Search results for "AEM"

showing 10 items of 1006 documents

Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study

2022

Although it is well known that lifestyle changes can affect plasma glucose levels, there is little formal evidence for the sustained effectiveness of exercise and diet in diabetes mellitus (DM) management. Self-care in DM refers to the real-life application of the knowledge that the patient gained during the education programmes. The goals are to bring about changes in the patient’s behaviour, thus improving glycaemic control. We evaluated the influence of DM self-care activities (SCA) on glycaemic control in a total of 159 patients with DM. Plasma glycated haemoglobin (HbA1c) levels were used to monitor glycaemic control, while SCA were assessed using the standardised Diabetes Self-M…

Diabetes mellitus Diabetes self-management questionnaire Glycaemic control Physical activity Prevention Self-care activitiesdiabetes mellitus; diabetes self-management questionnaire; physical activity; self-care activities; glycaemic control; preventionLeadership and ManagementHealth PolicyRphysical activityHealth Informaticsself-care activitiesArticleglycaemic controlpreventionHealth Information Managementdiabetes mellitusMedicinediabetes self-management questionnaire
researchProduct

Cyclic antibiotic therapy for diverticular disease: a critical reappraisal.

2010

Different symptoms have been attributed to uncomplicated diverticular disease (DD). Poor absorbable antibiotics are largely used for uncomplicated DD, mainly for symptom treatment and prevention of diverticulitis onset. Controlled trials on cyclic administration of rifaximin in DD patients were evaluated. Four controlled, including 1 double-blind and 3 open-label, randomized studies were available. Following a long-term cyclic therapy, a significant difference emerged in the global symptoms score (range: 0-18) between rifaximin plus fibers (from 6-6.5 to 1-2) and fibers alone (from 6.7 to 2-3.8), although the actual clinically relevance of such a very small difference remains to be ascertai…

Dietary FiberSettore MED/12 - GastroenterologiaEvidence-Based MedicinePatient SelectionRifamycinsDrug Administration ScheduleRifaximinAnti-Bacterial AgentsDiverticulumSettore MED/18 - Chirurgia GeneraleTreatment Outcomediverticular disease; diverticulitis; haemorrhage; rifaximin; symptoms; therapyHumansDiverticular diseasetherapysymptoms rifaximin diverticulitisDiverticulitis
researchProduct

Revision of the plant bug genus Xenocylapidius (Hemiptera, Heteroptera, Miridae, Cylapinae), with descriptions of five new species from Australia and…

2014

Abstract The genus Xenocylapidius Gorczyca, 1997 is revised. Five new species: Xenocylapidius acutipennis sp. n., Xenocylapidius ater sp. n., Xenocylapidius bimaculatus sp. n., Xenocylapidius gemellus sp. n., and Xenocylapidius rolandi sp. n. are described from Australia and New Caledonia. Illustrations of the male genitalia, color photographs of dorsal and lateral views of the adults of all species, and key to species of the genus Xenocylapidius are provided.

DorsumInsectaCylapinaeArthropodaMiridaeMiridaeCylapinaeMale genitaliaZoologyReview ArticleBiologyAustralian RegionHemipteraHeteropteraXenocylapidiusNew Caledonialcsh:ZoologyMiroideaAnimalialcsh:QL1-991Ecology Evolution Behavior and Systematicsnew speciesHemipteraHeteropteraAnimaliaHeteropteraAustraliaCylapinaebiology.organism_classificationHemipteraMiridaeKey (lock)Animal Science and ZoologyTaxonomy (biology)keysMiridaeXenocylapidiusAnimalia
researchProduct

Cross‐sectional comparative study of pharmacokinetics and efficacy between sucrose‐formulated recombinant factor VIII (Kogenate ® ) and BAY 81‐8973 (…

2019

Drug compoundingmedicine.medical_specialtyCross-sectional studybusiness.industryTreatment outcomeHematologyGeneral MedicineModerate haemophilia ARecombinant factor viiiPharmacokineticsInternal medicinemedicineIn patientYoung adultbusinessGenetics (clinical)Haemophilia
researchProduct

Drug-related cardiotoxicity for the treatment of haematological malignancies in elderly.

2010

Several publications have focused on the cardiotoxicity of specific classes of haematological therapeutic agents such as antracyclines and cyclofosfamide. Cardiotoxicity of cancer chemotherapeutics is a problem for patients of all ages, but it increases with age. Toxicity can also be developed months after the last chemotherapy dose, and late reactions can be seen years later when they present new-onset cardiomyopathy. No data are available about the cardiotoxicity of non-chemotherapy agents currently used as preferred therapy for haematological malignancy in elderly. In this review we have provided a summary of the cardiovascular toxic effects produced by different drugs and therapeutic ag…

Drugmedicine.medical_specialtyHeart diseaseHeart Diseasesmedicine.medical_treatmentmedia_common.quotation_subjectCardiomyopathyAntineoplastic AgentsPharmacologyCardiotoxinsDrug Delivery SystemsDrug DiscoverymedicineAnimalsHumansIntensive care medicinedrug cardiotoxicity haematological malignanciesmedia_commonAgedPharmacologyCardiotoxicityChemotherapybusiness.industryAge FactorsCancerImatinibmedicine.diseaseHematologic NeoplasmsRituximabbusinessmedicine.drugCurrent pharmaceutical design
researchProduct

Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

2014

Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins represent the evidence-based treatment of choice for reducing low-density lipoprotein cholesterol levels and decreasing cardiovascular events. Unfortunately, statins are frequently not available for several reasons, including intolerance, side effects or, simply, patient preference. Nutraceuticals and functional food ingredients that are beneficial to vascular health may represent useful compounds that are able to reduce the overall cardiovascular risk induced by dyslipidaemia by acting parallel to statins or as adjuvants in case of failure or in situations where statins cannot be used. The mechanisms…

DyslipidaemiaMedicine (miscellaneous)Pharmacologychemistry.chemical_compoundPharmacotherapyNutraceuticalFunctional foodMedicineTX341-641Nutrition and DieteticsCholesterolbusiness.industryNutrition. Foods and food supplyStatinsnutritional and metabolic diseasesPatient preferenceCardiovascular diseaseschemistryMrna levelnutrizione; Nutraceuticallipids (amino acids peptides and proteins)NutraceuticalsDrug therapyFaecal excretionbusinessFood ScienceLipoprotein
researchProduct

Consenso Delphi sobre el diagnóstico y manejo de la dislipidemia en pacientes con enfermedad renal crónica: análisis post-hoc del estudio DIANA

2016

Resumen Antecedentes y objetivos: Este estudio post hoc analizó la percepción de la importancia de la enfermedad renal crónica (ERC) en el cribado de la dislipidemia y en la elección del tratamiento con estatinas entre médicos de Atención Primaria (MAP) y otras especialidades mediante cuestionario Delphi. Métodos: El cuestionario incluyó 4 bloques de preguntas alrededor del paciente dislipémico con alteración del metabolismo hidrocarbonado. Aquí se presentan los resultados relacionados con la consideración de la ERC en el cribado y la elección de la estatina. Resultados: De los 497 expertos incluidos, el 58% eran MAP y el 42%, especialistas (35, el 7%, nefrólogos). Hubo consenso en realizar…

DyslipidaemiaPulmons -- Malalties obstructivesRiesgo cardiovascularDelphi Technique030204 cardiovascular system & hematologylcsh:RC870-923urologic and male genital diseases0302 clinical medicineRisk FactorsSurveys and QuestionnairesChronic kidney diseaseMedicine030212 general & internal medicinecomputer.programming_languagemedicine.diagnostic_testLipidsfemale genital diseases and pregnancy complicationsCardiovascular DiseasesNephrologylipids (amino acids peptides and proteins)medicine.symptomEstatinasGlomerular Filtration Ratemedicine.medical_specialtyConsensusStatinRonyons -- Malaltiesmedicine.drug_classRenal function03 medical and health sciencesInternal medicineDislipidemiaPost-hoc analysisAlbuminuriaHumansRenal Insufficiency ChronicIntensive care medicineEnfermedad renal crónicaDyslipidemiasbusiness.industryStatinsnutritional and metabolic diseasesGuidelineCardiovascular risklcsh:Diseases of the genitourinary system. Urologymedicine.diseaseEndocrinologyAlbuminuriabusinessLipid profilecomputerDelphiKidney diseaseNefrología (English Edition)
researchProduct

Consenso Delphi sobre el diagnóstico y manejo de la dislipidemia en pacientes con enfermedad renal crónica: análisis post-hoc del estudio DIANA

2016

ResumenAntecedentes y objetivosEste estudio post hoc analizó la percepción de la importancia de la enfermedad renal crónica (ERC) en el cribado de la dislipidemia y en la elección del tratamiento con estatinas entre médicos de Atención Primaria (MAP) y otras especialidades mediante cuestionario Delphi.MétodosEl cuestionario incluyó 4bloques de preguntas alrededor del paciente dislipémico con alteración del metabolismo hidrocarbonado. Aquí se presentan los resultados relacionados con la consideración de la ERC en el cribado y la elección de la estatina.ResultadosDe los 497 expertos incluidos, el 58% eran MAP y el 42%, especialistas (35, el 7%, nefrólogos). Hubo consenso en realizar un cribad…

DyslipidaemiaRiesgo cardiovascularStatins030204 cardiovascular system & hematologylcsh:Diseases of the genitourinary system. Urologylcsh:RC870-923Cardiovascular risk03 medical and health sciences0302 clinical medicineNephrologyChronic kidney diseaseDislipidemia030212 general & internal medicineEnfermedad renal crónicaEstatinasNefrología
researchProduct

Rapid Expansion of Acute Myeloid Leukemia-Reactive Cytotoxic T Cells from CD8+CD62L+ Blood Lymphocytes of HLA-Matched Healthy Donors In Vitro

2006

Abstract Allogeneic cytotoxic T-lymphocyte (CTL) therapy in acute myeloid leukemia (AML) is hampered by the poor efficiency of growing leukemia-reactive CTLs from healthy donors in vitro. We established an allogeneic mini-mixed lymphocyte-leukemia culture (MLLC) approach by stimulating comparably small numbers (104/well) of CD8+ T cells isolated from healthy donors against irradiated primary AML blasts in 96-well plates. Prior to use, CD8+ T cells were immunomagnetically separated into a CD62L(high)+ subset enriched for naive precursors and central memory cells as well as a CD62L(low)+/negative subset containing effector memory cells. The culture medium contained IL-7, IL-12, and IL-15. Aft…

ELISPOTImmunologyMyeloid leukemiaCell BiologyHematologyHuman leukocyte antigenBiologyBiochemistryHaematopoiesisCTL*Antigenhemic and lymphatic diseasesImmunologyCytotoxic T cellCD8Blood
researchProduct

An uncommon complication of liver biopsy: obstructive jaundice from blood clots

2005

Introduction: The AA. report on a case of one young woman who developed obstructive jaundice induced by hemo- bilia after percutaneous liver biopsy, successfully treated with endoscopic retrograde cholangiopancreatography (ERCP) Methods: An endoscopic sphincterotomy was performed with extraction of the clots Observations: Four weeks after ERCP the patient was healthy and asymptomatic, valuated as outpatient Conclusions: The role of ERCP in managing biliary sequelae of hemobilia is well established: biliary decompression is required if and intrabiliary lot causes obstructive jaundice and/or biliary colic. ERCP is feasible and leads to relief of symptoms in most cases, without the need of sur…

ERCPhaemobilialiver biopsyobstructive jaundice
researchProduct